MedTrace Logo

Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine

NCT03725579 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2018-11-01

No results posted yet for this study

Summary

The aim of this prospective randomized clinical trial was compare between 2% Mepivacaine and 4% Articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars as regards to their anesthetic efficiency; during access cavity preparation and instrumentation.

Conditions

  • Symptomatic Irreversible Pulpitis

Interventions

DRUG

mepivicane hydrochloride

Pain will be assessed during access cavity preparation and instrumentation

DRUG

articane hydrochloride

Pain will be assessed during access cavity preparation and instrumentation

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Marwa Bedier, PHD · Cairo university, faculty of dentistry

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03725579 on ClinicalTrials.gov